Genetic analysis of methicillin-resistant Staphylococcus aureus expressing high- and low-level mupirocin resistance

J Med Microbiol. 2001 Oct;50(10):909-915. doi: 10.1099/0022-1317-50-10-909.

Abstract

Clinical strains of methicillin-resistant Staphylococcus aureus (MRSA) expressing high- and low-level mupirocin resistance were studied to determine the genetic location of mupirocin and other resistance determinants. Mupirocin resistance was confirmed by MIC determination with E-test strips. Curing and transfer experiments were used to establish the genetic location of the resistance determinants and the PCR with mupA-specific primers was used to detect the presence of mupA genes. High-level mupirocin-resistant isolates had MICs >1024 mg/L, whereas the low-level resistant isolates had MICs of 32-128 mg/L. The isolates carried plasmids ranging from 2.8 to 38 kb in size. All of them carried 26- and 3.0-kb plasmids, but only the high-level mupirocin-resistant isolates carried a 38-kb plasmid. Curing and transfer experiments revealed that the 26-kb plasmid encoded resistance to cadmium, mercuric chloride, propamidine isethionate and ethidium bromide and the 38-kb plasmid was a conjugative plasmid encoding high-level mupirocin resistance. One isolate, IBN287, carried both plasmid-borne high-level and chromosomal low-level mupirocin resistance. The mupA gene was detected on the 38-kb plasmid DNA but not in the genomic DNA of the low-level mupirocin-resistant isolates. The genomic DNA of strain IBN287 cured of the 38-kb mupirocin resistance plasmid did not contain mupA. The results suggest that different genes encoded low- and high-level mupirocin resistance in these isolates.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Conjugation, Genetic / genetics
  • DNA, Bacterial / genetics
  • Drug Resistance, Microbial
  • Drug Resistance, Multiple / genetics*
  • Humans
  • Methicillin Resistance / genetics*
  • Mupirocin / pharmacology*
  • Plasmids / chemistry
  • Polymerase Chain Reaction
  • Staphylococcal Infections / drug therapy
  • Staphylococcal Infections / microbiology
  • Staphylococcus aureus / drug effects*
  • Staphylococcus aureus / genetics
  • Staphylococcus aureus / isolation & purification
  • beta-Lactamases / analysis
  • beta-Lactamases / biosynthesis

Substances

  • Anti-Bacterial Agents
  • DNA, Bacterial
  • Mupirocin
  • beta-Lactamases